Tetragon
Financial Group Limited 2024
Annual Report
LONDON, March
4, 2025 -- Tetragon
has published its 2024 Annual Report. Please click below to access
the report.
Tetragon Financial Group Limited 2024 Annual Report
As a
reminder, Tetragon will host a conference call for investors on
Wednesday, 5 March 2025 at
15:30 GMT / 10:30 EST to discuss its annual report and to
provide a company update.
During the
call, Tetragon's investment manager will also seek to address
questions raised by investors, including questions e-mailed to
ir@tetragoninv.com.
Getting
Access to the Call and Q&A:
The call
will be accompanied by a live presentation which can be viewed
online by registering at the link below. In addition, questions can
be submitted online while watching the presentation. We would
encourage you to log in 15 minutes prior to the start of the
call.
Webcast –
please use the following link to register and access the live event
webcast:
https://onlinexperiences.com/Launch/QReg/ShowUUID=BE8AB726-D9C7-4F63-B2F2-78D8F529C42E
Audio
conference –
please use the following link to register for your personal audio
conference call details if you cannot join the
webcast: https://emportal.ink/4avv97a
Presentation
Replay:
A replay
of the call will be available for 30 days through the link provided
above or by visiting http://www.tetragoninv.com/investors/calendar-and-events where
a recording will posted.
About
Tetragon:
Tetragon
is a Guernsey closed-ended investment company. Its non-voting
shares are listed on Euronext in Amsterdam, a regulated market of Euronext
Amsterdam N.V., and also traded on the Specialist Fund Segment of
the Main Market of the London Stock Exchange. Our investment
manager is Tetragon Financial Management LP. Find out more
at www.tetragoninv.com.
Tetragon's
non-voting shares are subject to restrictions on ownership by U.S.
persons and are not intended for European retail
investors.
Please
see: https://www.tetragoninv.com/shareholders/additional-information.
Tetragon
Investor Relations:
Yuko Thomas
ir@tetragoninv.com
Press
Inquiries:
Prosek
Partners
Pro-tetragon@prosek.com
U.K. +44
203 890 9193
U.S. +1
212 279 3115
This release contains inside information within the
meaning of Article 7(1) of the EU
Market Abuse Regulation (2014/596/EU), or EU MAR, and of the UK
version of EU MAR as it forms part of UK law by virtue of the
European Union (Withdrawal) Act (as
amended).
This release
does not contain
or constitute an offer to sell or
a solicitation of an offer to purchase
securities in
the United
States or
any other jurisdiction. The securities of Tetragon have not been
and will not be registered under the U.S. Securities Act of 1933,
as amended, and may not be offered or sold in the United States or to U.S. persons unless
they are registered under applicable law or exempt from
registration. Tetragon does not intend to register any portion of
its securities in the United
States or to conduct a public offer of securities in
the United States. In addition,
Tetragon has not been and will not be registered under the U.S.
Investment Company Act of 1940, as amended, and investors will not
be entitled to the benefits of such Act. Tetragon is registered in
the public register of the Netherlands Authority for the Financial
Markets (Autoriteit
Financiële Markten) under
Section 1:107 of the Dutch Financial Markets Supervision Act as an
alternative investment fund from a designated state.